GlassScriptPhysician profile
Sam T Hwang
NPI 1760500813
$31,907.59
in general payments reported to CMS, 2019-2025
9 companies · $13K in 2025
The $13K reported for 2025 was more than what 93% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,891 · 2022: $3,707 · 2023: $8,458 · 2024: $20.04 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $7,661 · Food and Beverage: $929 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $751 · Education: $71.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,898.00 |
| Travel and Lodging | $7,660.88 |
| Food and Beverage | $928.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $750.53 |
| Education | $71.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $10,402.39 | 2019-2025 | Poteligeo |
| Kyowa Kirin Co., LTD | $8,606.41 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $8,153.70 | 2023 | Sotyktu |
| Incyte Corporation | $2,800.00 | 2022 | |
| Janssen Scientific Affairs, LLC | $907.49 | 2022 | |
| Shionogi INC | $750.53 | 2025 | |
| Sun Pharmaceutical Industries INC. | $198.47 | 2019-2025 | |
| Genzyme Corporation | $58.60 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $30.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Hwang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.